Dermavant Sciences, an Organon company
Company Details
Status: Private
Employees: 101-250
Location:
3780 Kilroy Airport Way, Suite 250, Long Beach, CA 90806, US
Type:
sample
Technology:
sample
About: Dermavant Sciences, an Organon company, is a biotechnology firm focused on immuno-dermatology. The company specializes in developing innovative therapies for chronic skin conditions, particularly plaque psoriasis and atopic dermatitis. Acquired by Organon in October 2024, Dermavant aims to address unmet medical needs in dermatology through efficient research and clinical development.
Dermavant's flagship product is VTAMA® (tapinarof) cream, which is FDA-approved for treating mild to severe plaque psoriasis in adults. The company is also advancing its pipeline with promising results in atopic dermatitis and developing DMVT-506, a next-generation treatment for inflammatory diseases. With a commitment to patient-centric innovation, Dermavant seeks to redefine standards of care in dermatology through scientifically validated therapies. The company operates with a team of 201–500 employees, primarily based in California, and utilizes advanced tools for data analytics and clinical research.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Dermavant Sciences, an Organon company | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.